PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.233
https://www.valueinhealthjournal.com/article/S1098-3015(11)01795-5/fulltext
Title : PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01795-5&doi=10.1016/j.jval.2011.08.233
First page : A273
Section Title : Infection
Open access? : No
Section Order : 210
Categories :
Tags :
Regions :
ViH Article Tags :